GlassScriptPhysician profile
Gregory Schneider
NPI 1679533285
$1,539.14
in general payments reported to CMS, 2019-2025
12 companies · $791 in 2025
The $791 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.75 · 2020: $18.20 · 2021: $48.17 · 2022: $60.75 · 2024: $591 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733 · Education: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.79 |
| Education | $648.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $628.48 | 2024-2025 | Actis |
| Depuy Synthes Sales INC. | $294.39 | 2024-2025 | Na, Va-Lcp |
| Stryker Corporation | $198.34 | 2022-2025 | Inspace |
| Abbott Laboratories | $133.92 | 2024 | Cardiomems |
| Abbvie INC. | $117.84 | 2025 | |
| Johnson & Johnson Health Care Systems INC. | $35.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.62 | 2019-2020 | |
| Boston Scientific Corporation | $26.30 | 2022 | |
| Ethicon US, LLC | $22.75 | 2024 | Stratafix, Dermabond |
| Csl Behring | $20.00 | 2024 | Kcentra |
| E.R. Squibb & Sons, L.L.C. | $16.33 | 2019 | |
| Pfizer INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.